1. Home
  2. CLMT vs PBLS Comparison

CLMT vs PBLS Comparison

Compare CLMT & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calumet Specialty Products Partners L.P.

CLMT

Calumet Specialty Products Partners L.P.

HOLD

Current Price

$59.01

Market Cap

3.4B

Sector

Energy

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$41.47

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLMT
PBLS
Founded
1916
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.6B
IPO Year
2024
2026

Fundamental Metrics

Financial Performance
Metric
CLMT
PBLS
Price
$59.01
$41.47
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$28.65
N/A
AVG Volume (30 Days)
1.1M
489.4K
Earning Date
05-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
85.39
N/A
EPS
N/A
N/A
Revenue
$4,137,100,000.00
N/A
Revenue This Year
$3.94
N/A
Revenue Next Year
$1.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.42
$25.56
52 Week High
$59.67
$42.49

Technical Indicators

Market Signals
Indicator
CLMT
PBLS
Relative Strength Index (RSI) 75.69 62.12
Support Level $30.74 $37.77
Resistance Level N/A $41.34
Average True Range (ATR) 2.31 2.26
MACD 0.32 -0.13
Stochastic Oscillator 92.77 80.55

Price Performance

Historical Comparison
CLMT
PBLS

About CLMT Calumet Specialty Products Partners L.P.

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: